Several sulfated polysaccharides (dextran sulfate, pentosan polysulfate, fucoidan, and carrageenans) proved to be potent inhibitors for herpes simplex virus, human cytomegalovirus, vesicular stomatitis virus, Sindbis virus, and human immunodeficiency virus. They were moderately inhibitory to vaccinia virus but not inhibitory to adenovirus, coxsackievirus, poliovirus, parainfluenza virus, and reovirus. These results indicate that, with the exception of parainfiuenza virus, enveloped viruses are specifically susceptible to the inhibitory activity of sulfated polysaccharides.
The inhibitory effects of polyanionic substances on the replication of herpes simplex virus (HSV) and other viruses were reported more than two decades ago (7, 11) . However, these observations did not generate much interest because the antiviral action of the compounds was considered to be largely nonspecific. Interest on the antiviral potential of sulfated polysaccharides regained momentum when recent studies showed that dextran sulfate and heparin are highly inhibitory to the replication of human immunodeficiency virus type 1 (HIV-1) in vitro (9, 14) . We have now evaluated several sulfated polysaccharides for their activities against a variety of DNA ard RNA viruses and found that, as a rule, these compounds are potent and selective inhibitors of enveloped viruses, irrespective of whether these were DNA or RNA viruses.
Dextran sulfates (approximate molecular weights [MW] of 1,000, 10,000, 40,000, 70,000, 110,000, and 500,000) were cell (HUT-78/HTLV-IIIB). The HTLV-I-carrying T4 cell line, MT-4, is described elsewhere (8, 12) . The Vero, HeLa, and MT-4 cell lines used in this study were regularly exam-* Corresponding author. ined for mycoplasma contamination and found to be mycoplasma free.
Except for the procedure of the anti-HIV-1 assay, the procedures for assays have been described previously (1) (2) (3) (4) (5) HSV-1, and CMV) ( Table 1) . Of the six compounds tested, pounds at 100 jig/ml (data not shown). Thus, the sulfated dextran sulfate (MW, 10,000) and fucoidan were the most polysaccharides were not toxic to the host cells at concenpotent inhibitors of herpesviruses, and heparin was the trations that were at least 100-fold in excess of those found to weakest. Vaccinia virus was inhibited only at relatively high be inhibitory to virus replication. concentrations of the compounds (10 to 200 j,g/ml). Adeno-A marked difference was found in the susceptibility to virus replication was not affected by any of the compounds, heparin of VSV in PRK and HeLa cells (Table 1) . This even at 200 ,ug/ml (Table 1) . finding suggested that there are possible differences in the When the six sulfated polysaccharides were evaluated for virus-inhibitory effects of the sulfated polysaccharides, deactivity against RNA viruses, the compounds were found to pending on the choice of cell line. Therefore, the inhibitory be active against VSV, Sindbis virus, and HIV-1. However, effect of the sulfated polysaccharides on VSV was further the compounds were inactive against coxsackievirus, polioexamined in a variety of cell lines. Except for heparin, all virus, and parainfluenza virus (Table 1) . Similarly, reovirus compounds showed marked antiviral activity in all cell lines was not susceptible to the inhibitory effects of the comtested (Table 2) . However, the anti-VSV activity was most pounds except for pentosan polysulfate (MIC, 70 jig/ml). pronounced in PRK cells. This effect was shown not only by HIV-1 was very susceptible to all sulfated polysaccharides; heparin but also by fucoidan and K-and X-carrageenan. VSV also showed high susceptibility (Table 1) .
Various samples of dextran sulfate with MWs ranging Except for K-and X-carrageenan, which affected Vero from 1,000 to 500,000 was examined for their antiviral cells, none of the test compounds disturbed normal cell activity. A marked increased in antiviral activity, irrespecmorphology at a concentration of 200 ,g/ml (for PRK and tive of the virus (vaccinia virus, HSV-1, TK-HSV-1, HEL cells) or 400 jig/ml (for HeLa and Vero cells) (data not HSV-2, CMV, Sindbis virus, HIV-1, and VSV), was obshown). The morphology of Vero cells was altered by K-and served when the MW of dextran sulfate increased from 1,000 X-carrageenan at concentrations of 40 and 4 ,ug/ml, respecto 10,000 (Fig. 1) . When the MW further increased from tively. The compounds were not inhibitory to the cell 10,000 to 500,000, the antiviral activity of dextran sulfate proliferations of HEL and MT-4 cells at concentrations tended to level off. Thus, a MW of 10,000 seems optimal for ranging from 100 to 400 ,g/ml. Neither DNA nor RNA the virus-inhibitory effect of dextran sulfate. synthesis of PRK cells was inhibited by any of the comIt has been postulated that anionic polysaccharides can interfere with a very early stage of the virus replication cycle, presumably virus adsorption (7) . To assess the possible inhibitory effect of dextran sulfate (MW, 10,000) on the virus adsorption stage, two treatment regimens, A and B, were installed. In treatment A, the cells were exposed to the virus in the presence of the test compounds and incubated for 1 h at 37°C (normal treatment). In treatment B, the cells were exposed to the virus in the absence of the compound and incubated for 1 h at 37°C. After either treatment A or B, unadsorbed virus was removed, and the cells were further incubated in the presence of the compounds. The virusinhibitory effect of dextran sulfate (MW, 10,000) was considerably reduced, if not completely eliminated, when the compound was added only after virus adsorption had taken place ( Table 3 ).
The present study clearly indicates that sulfated polysaccharides have a broad-spectrum antiviral activity against enveloped viruses. In particular, dextran sulfate is a potent inhibitor of CMV and HIV-1 ( Table 1 ). The MIC of dextran sulfate (MW, 10,000) for CMV and HIV-1 is 0.5 ,ug/ml, whereas the compound is not inhibitory to host cell (HEL or MT-4) proliferation even at 400 ,ug/ml (data not shown). This (13) . The mechanism of action of sulfated polysaccharides has been attributed to the inhibition of virus adsorption to the host cells (7) . This phenomenon was not further addressed until it was recently proven that dextran sulfate and heparin block the attachment of HIV-1 particles to target T lymphocytes (lb, 10) . The present observations (Table 3) suggest that dextran sulfate blocks the binding of HIV-1 and other enveloped viruses (i.e., HSV-1, HSV-2, vaccinia virus, and VSV) to cells. The activity of dextran sulfate against HSV-1 or -2 and VSV may form the basis for a bioassay to monitor levels of the compound in blood following its administration to patients.
Before sulfated polysaccharides can be recommended for treatment of virus infections, further investigations of their in vivo antiviral activity, pharmacokinetics, and toxicology are required. Heparin and sulfated polysaccharides have anticoagulant activity, and obviously, this activity may hamper their practical usefulness. However, we have previously demonstrated that dextran sulfate, pentosan polysulfate, fucoidan, and carrageenans achieve their in vitro inhibitory effect on HIV-1 at concentrations that are more than 100-fold lower than the anticoagulant threshold (1 IU) (la). From the data presented in this paper, it appears that the compounds are about equally inhibitory to several RNA and DNA viruses other than HIV-1, including HSV-1, HSV-2, CMV, and VSV. Thus, dextran sulfate and its congeners are inhibitory to a variety of enveloped viruses at concentrations far below their anticoagulant threshold. This activity points to their potential as drugs for the chemotherapy of virus infections.
